Literature DB >> 11265635

The murine mutation scurfy (sf) results in an antigen-dependent lymphoproliferative disease with altered T cell sensitivity.

J L Zahorsky-Reeves1, J E Wilkinson.   

Abstract

The scurfy (sf) murine mutation results in a rapidly fatal lymphoproliferative disease, causing death by 26 days. Mature CD4+ T cells which tested hyperresponsive to T cell receptor (TCR) stimulation are involved. When sf was bred onto a transgenic line (DO11.10) in which 75 - 95 % of the T cells express TCR for ovalbumin (OVA) 323 - 339, sf / Y OVA mice had prolonged lifespans and less severe clinical symptoms compared to controls. However, sf / Y OVA mice eventually developed disease and died with manifestations similar to those of the original sf strain. The Rag1 knockout (KO) mouse, which cannot produce mature T (or B) cells without the addition of functional transgenes, was chosen for further breeding. The combination of Rag1 KO, the OVA transgene, and sf produced mice with 100 % of their mature DO11.10 alpha beta T cells reactive strictly to OVA peptide. None of these Rag1 - / - sf / Y OVA mice developed the scurfy disease. They retained central deletion capability in vivo, but demonstrated an altered in vitro response to OVA peptide. These results indicate that mice without TCR for endogenous antigens do not develop scurfy symptoms, and are consistent with the hypothesis that the sf mutation requires antigen stimulation to manifest disease, perhaps via altered TCR sensitivity.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11265635     DOI: 10.1002/1521-4141(200101)31:1<196::AID-IMMU196>3.0.CO;2-9

Source DB:  PubMed          Journal:  Eur J Immunol        ISSN: 0014-2980            Impact factor:   5.532


  14 in total

Review 1.  Genetic control of the inflammatory T-cell response in regulatory T-cell deficient scurfy mice.

Authors:  Rahul Sharma; Shyr-Te Ju
Journal:  Clin Immunol       Date:  2010-05-08       Impact factor: 3.969

2.  Prospective immunological profiling in a case of immune dysregulation, polyendocrinopathy, enteropathy, X-linked syndrome (IPEX).

Authors:  A C Bakke; M Z Purtzer; R S Wildin
Journal:  Clin Exp Immunol       Date:  2004-08       Impact factor: 4.330

3.  Emergence of T cells that recognize nonpolymorphic antigens during graft-versus- host disease.

Authors:  Hemalatha Rangarajan; Maryam Yassai; Hariharan Subramanian; Richard Komorowski; Megan Whitaker; Jack Gorski; William R Drobyski
Journal:  Blood       Date:  2012-04-10       Impact factor: 22.113

4.  Pervasive and stochastic changes in the TCR repertoire of regulatory T-cell-deficient mice.

Authors:  Lingjie Zheng; Rahul Sharma; John T Kung; Umesh S Deshmukh; Wael N Jarjour; Shu Man Fu; Shyr-Te Ju
Journal:  Int Immunol       Date:  2008-02-28       Impact factor: 4.823

5.  How defects in central tolerance impinge on a deficiency in regulatory T cells.

Authors:  Zhibin Chen; Christophe Benoist; Diane Mathis
Journal:  Proc Natl Acad Sci U S A       Date:  2005-10-03       Impact factor: 11.205

6.  IL-1R1 is expressed on both Helios(+) and Helios(-) FoxP3(+) CD4(+) T cells in the rheumatic joint.

Authors:  M Müller; J Herrath; V Malmström
Journal:  Clin Exp Immunol       Date:  2015-07-30       Impact factor: 4.330

Review 7.  Clinical and molecular features of the immunodysregulation, polyendocrinopathy, enteropathy, X linked (IPEX) syndrome.

Authors:  R S Wildin; S Smyk-Pearson; A H Filipovich
Journal:  J Med Genet       Date:  2002-08       Impact factor: 6.318

8.  Rapid and selective expansion of nonclonotypic T cells in regulatory T cell-deficient, foreign antigen-specific TCR-transgenic scurfy mice: antigen-dependent expansion and TCR analysis.

Authors:  Rahul Sharma; Angela Chiao-Ying Ju; John T Kung; Shu Man Fu; Shyr-Te Ju
Journal:  J Immunol       Date:  2008-11-15       Impact factor: 5.422

Review 9.  FOXP3 and scurfy: how it all began.

Authors:  Fred Ramsdell; Steven F Ziegler
Journal:  Nat Rev Immunol       Date:  2014-04-11       Impact factor: 53.106

10.  Deficiency in regulatory T cells results in development of antimitochondrial antibodies and autoimmune cholangitis.

Authors:  Weici Zhang; Rahul Sharma; Shyr-Te Ju; Xiao-Song He; Yanyan Tao; Koichi Tsuneyama; Zhigang Tian; Zhe-Xiong Lian; Shu Man Fu; M Eric Gershwin
Journal:  Hepatology       Date:  2009-02       Impact factor: 17.425

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.